Search Within

Aisha Nasreen Hasan

Formats
  1. Meeting Abstract (35)
  2. Journal Article (18)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Review (1)
Groups
  1. Pediatrics, Department of (56)
  2. Stem Cell Transplantation and Cellular Therapy Service (56)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (53)
  4. Department of Medicine (53)
  5. GSK Faculty (53)
  6. Immunology Program Faculty (53)

More Groups

People
  1. Richard O'Reilly (53)
  2. Ekaterina Doubrovina (32)
  3. Susan Prockop (30)
  4. Guenther Koehne (18)
  5. Annamalai Selvakumar (16)
  6. Nancy Kernan (15)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Blood (22)
  2. Biology of Blood and Marrow Transplantation (10)
  3. Bone Marrow Transplantation (5)
  4. Cytotherapy (2)
  5. Journal of Clinical Investigation (2)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. Elsevier Inc. (12)
  3. Nature Publishing Group (6)
  4. American Society for Clinical Investigation (2)
  5. Elsevier Science Ltd. (2)
  6. Amer Soc Clinical Investigation Inc (1)

More Publishers

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Human CMVpp65-specific stem cell-like memory T-cells (T(SCM)) are a principal source for rapid repopulation of immunodominant central memory (T(CM)) and effector memory (T(EM)) in the circulation
    Meeting Abstract

    Kuo, T. Y.; Hasan, A.; Guerreiro, M.; O'Reilly, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8(+) T cells for adoptive immunotherapy of cancer and infections
    Journal Article

    Hasan, A. N.; Selvakumar, A.; Shabrova, E.; Liu, X. R.; Afridi, F.; Heller, G.; Riviere, I.; Sadelain, M.; Dupont, B.; O'Reilly, R. J.
    Clinical and Experimental Immunology (2016)

    Fulltext@MSK | Save
  • Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
    Journal Article

    O'Reilly, R. J.; Prockop, S.; Hasan, A. N.; Koehne, G.; Doubrovina, E.
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • T- cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic GVHD and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) with AML in CR1
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Wolden, S.; Curran, K. J.; Hasan, A. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Successful treatment of refractory CMV chorioretinitis and meningoencephalitis with adoptive transfer of third party CMVpp65 specific T-cell Lines
    Meeting Abstract

    Prockop, S.; Hasan, A.; Doubrovina, E.; Castro-Malaspina, H. R.; Barker, J. N.; Dahi, P. B.; Boulad, F.; Kernan, N. A.; Koehne, G.; Sauter, C. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • T-cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic Gvhd and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (<21 years) with AML in CR1 or CR2 or MDS including tMDS/AML
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S.; Wolden, S.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Curran, K. J.; Hasan, A. N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Adoptively transferred CMV-specific T-cells responsive to immunodominant CMVpp65 epitopes extend durable in-vivo suppression of clonogenic CMVpp65 [+] human colon carcinoma cells in comparison to T-cells responsive to subdominant epitopes
    Meeting Abstract

    Hasan, A. N.; Selvakumar, A.; Kuo, T. Y.; O'Reilly, R. J.
    Blood (2015)

    Fulltext@MSK | Save